BACKGROUND: The magnitude of risk conferred by the interaction between tobacco and alcohol use on the risk of head and neck cancers is not clear because studies have used various methods to quantify the excess head and neck cancer burden. METHODS: We analyzed individual-level pooled data from 17 European and American case-control studies (11,221 cases and 16,168 controls) participating in the International Head and Neck Cancer Epidemiology consortium. We estimated the multiplicative interaction parameter (psi) and population attributable risks (PAR). RESULTS: A greater than multiplicative joint effect between ever tobacco and alcohol use was observed for head and neck cancer risk (psi = 2.15; 95% confidence interval, 1.53-3.04). The PAR for tobacco or alcohol was 72% (95% confidence interval, 61-79%) for head and neck cancer, of which 4% was due to alcohol alone, 33% was due to tobacco alone, and 35% was due to tobacco and alcohol combined. The total PAR differed by subsite (64% for oral cavity cancer, 72% for pharyngeal cancer, 89% for laryngeal cancer), by sex (74% for men, 57% for women), by age (33% for cases <45 years, 73% for cases >60 years), and by region (84% in Europe, 51% in North America, 83% in Latin America). CONCLUSIONS: Our results confirm that the joint effect between tobacco and alcohol use is greater than multiplicative on head and neck cancer risk. However, a substantial proportion of head and neck cancers cannot be attributed to tobacco or alcohol use, particularly for oral cavity cancer and for head and neck cancer among women and among young-onset cases.
BACKGROUND: The magnitude of risk conferred by the interaction between tobacco and alcohol use on the risk of head and neck cancers is not clear because studies have used various methods to quantify the excess head and neck cancer burden. METHODS: We analyzed individual-level pooled data from 17 European and American case-control studies (11,221 cases and 16,168 controls) participating in the International Head and Neck Cancer Epidemiology consortium. We estimated the multiplicative interaction parameter (psi) and population attributable risks (PAR). RESULTS: A greater than multiplicative joint effect between ever tobacco and alcohol use was observed for head and neck cancer risk (psi = 2.15; 95% confidence interval, 1.53-3.04). The PAR for tobacco or alcohol was 72% (95% confidence interval, 61-79%) for head and neck cancer, of which 4% was due to alcohol alone, 33% was due to tobacco alone, and 35% was due to tobacco and alcohol combined. The total PAR differed by subsite (64% for oral cavity cancer, 72% for pharyngeal cancer, 89% for laryngeal cancer), by sex (74% for men, 57% for women), by age (33% for cases <45 years, 73% for cases >60 years), and by region (84% in Europe, 51% in North America, 83% in Latin America). CONCLUSIONS: Our results confirm that the joint effect between tobacco and alcohol use is greater than multiplicative on head and neck cancer risk. However, a substantial proportion of head and neck cancers cannot be attributed to tobacco or alcohol use, particularly for oral cavity cancer and for head and neck cancer among women and among young-onset cases.
Authors: Zhengdong Zhang; Qiuling Shi; Zhensheng Liu; Erich M Sturgis; Margaret R Spitz; Qingyi Wei Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-05 Impact factor: 4.254
Authors: Yan Cui; Hal Morgenstern; Sander Greenland; Donald P Tashkin; Jenny Mao; Wei Cao; Wendy Cozen; Thomas M Mack; Zuo-Feng Zhang Journal: Int J Cancer Date: 2006-02-01 Impact factor: 7.396
Authors: R B Hayes; E Bravo-Otero; D V Kleinman; L M Brown; J F Fraumeni; L C Harty; D M Winn Journal: Cancer Causes Control Date: 1999-02 Impact factor: 2.506
Authors: Edward S Peters; Michael D McClean; Mei Liu; Ellen A Eisen; Nancy Mueller; Karl T Kelsey Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-02 Impact factor: 4.254
Authors: Elaine M Smith; Justine M Ritchie; Michael Pawlita; Linda M Rubenstein; Thomas H Haugen; Lubomir P Turek; Eva Hamsikova Journal: Int J Cancer Date: 2007-02-15 Impact factor: 7.396
Authors: Mia Hashibe; Paolo Boffetta; David Zaridze; Oxana Shangina; Neonila Szeszenia-Dabrowska; Dana Mates; Vladimir Janout; Eleonóra Fabiánová; Vladimir Bencko; Norman Moullan; Amelie Chabrier; Rayjean Hung; Janet Hall; Federico Canzian; Paul Brennan Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-04 Impact factor: 4.254
Authors: Gypsyamber D'Souza; Aimee R Kreimer; Raphael Viscidi; Michael Pawlita; Carole Fakhry; Wayne M Koch; William H Westra; Maura L Gillison Journal: N Engl J Med Date: 2007-05-10 Impact factor: 91.245
Authors: Mia Hashibe; Paul Brennan; Simone Benhamou; Xavier Castellsague; Chu Chen; Maria Paula Curado; Luigino Dal Maso; Alexander W Daudt; Eleonora Fabianova; Leticia Fernandez; Victor Wünsch-Filho; Silvia Franceschi; Richard B Hayes; Rolando Herrero; Sergio Koifman; Carlo La Vecchia; Philip Lazarus; Fabio Levi; Dana Mates; Elena Matos; Ana Menezes; Joshua Muscat; Jose Eluf-Neto; Andrew F Olshan; Peter Rudnai; Stephen M Schwartz; Elaine Smith; Erich M Sturgis; Neonilia Szeszenia-Dabrowska; Renato Talamini; Qingyi Wei; Deborah M Winn; David Zaridze; Witold Zatonski; Zuo-Feng Zhang; Julien Berthiller; Paolo Boffetta Journal: J Natl Cancer Inst Date: 2007-05-16 Impact factor: 13.506
Authors: Marni Stott-Miller; Chu Chen; Shu-Chun Chuang; Yuan-Chin Amy Lee; Stefania Boccia; Hermann Brenner; Gabriela Cadoni; Luigino Dal Maso; Carlo La Vecchia; Philip Lazarus; Fabio Levi; Keitaro Matsuo; Hal Morgenstern; Heiko Müller; Joshua Muscat; Andrew F Olshan; Mark P Purdue; Diego Serraino; Thomas L Vaughan; Zuo-Feng Zhang; Paolo Boffetta; Mia Hashibe; Stephen M Schwartz Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-12-05 Impact factor: 4.254
Authors: Lisa A Peterson; Emily L Bellile; Gregory T Wolf; Shama Virani; Andrew G Shuman; Jeremy M G Taylor; Laura S Rozek Journal: Head Neck Date: 2016-07-19 Impact factor: 3.147
Authors: Paolo Boffetta; Richard B Hayes; Samantha Sartori; Yuan-Chin A Lee; Joshua Muscat; Andrew Olshan; Deborah M Winn; Xavier Castellsagué; Zuo-Feng Zhang; Hal Morgenstern; Chu Chen; Stephen M Schwartz; Thomas L Vaughan; Victor Wunsch-Filho; Mark Purdue; Sergio Koifman; Maria P Curado; Marta Vilensky; Maura Gillison; Leticia Fernandez; Ana Menezes; Alexander W Daudt; Stimson Schantz; Guopei Yu; Gypsyamber D'Souza; Robert I Haddad; Carlo La Vecchia; Mia Hashibe Journal: Eur J Cancer Prev Date: 2016-07 Impact factor: 2.497